Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25268153 | 1.00 | SPHK1 (0.33) | SPHK1 | |
| SCHEMBL25247451 | 0.99 | SPHK1 (0.33) | SPHK1 | |
| SCHEMBL25247449 | 0.99 | SPHK1 (0.33) | SPHK1 | |
| SCHEMBL25255700 | 0.90 | SPHK1 (0.32) | SPHK1 | |
| SCHEMBL25255699 | 0.90 | SPHK1 (0.32) | SPHK1 | |
| SCHEMBL25717593 | 0.84 | SPHK1 (0.47) | SPHK1 | |
| SCHEMBL25257861 | 0.84 | SPHK1 (0.32) | SPHK1 | |
| SCHEMBL25257860 | 0.84 | SPHK1 (0.32) | SPHK1 | |
| SCHEMBL25717581 | 0.83 | SPHK1 (0.47) | SPHK1 | |
| SCHEMBL25266950 | 0.80 | SPHK1 (0.30) | SPHK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4238979-A1 | BETA-STRAND TYPE CROSSLINKED PEPTIDE | Xeno-Interface Inc. (JP) | 2023-09-06 | — | — | EP | disclosed |
| CN-116710116-A | Beta-sheet femoral bridge peptide | Ｘｅｎｏ－Ｉｎｔｅｒｆａｃｅ株式会社 | 2023-09-05 | — | — | CN | disclosed |
| US-20230174576-A1 | BETA-STRAND BRIDGE PEPTIDE | KYOTO UNIVERSITY (JP) | 2023-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230174576-A1 | BETA-STRAND BRIDGE PEPTIDE | IAPP, SPPL2B, VIP | SPHK1 3697/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.